InfuSystems Holdings Inc - Asset Resilience Ratio
InfuSystems Holdings Inc (INFU) has an Asset Resilience Ratio of 0.17% as of March 2021. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See INFU working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2006–2017)
This chart shows how InfuSystems Holdings Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see INFU current and non-current assets.
Liquid Assets Composition Over Time
This chart breaks down InfuSystems Holdings Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore InfuSystems Holdings Inc long-term investment allocation to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $158.00K | 0.17% |
| Total Liquid Assets | $158.00K | 0.17% |
Asset Resilience Insights
- Limited Liquidity: InfuSystems Holdings Inc maintains only 0.17% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
InfuSystems Holdings Inc Industry Peers by Asset Resilience Ratio
Compare InfuSystems Holdings Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Vitrolife AB
ST:VITR |
Medical Devices | 7.27% |
|
Xiangyu Medical Co. Ltd. A
SHG:688626 |
Medical Devices | 1.53% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Tellgen Corp
SHE:300642 |
Medical Devices | 9.96% |
|
Stratec SE
XETRA:SBS |
Medical Devices | 0.29% |
|
T&R Biofab Co. Ltd
KQ:246710 |
Medical Devices | 0.12% |
|
Heramed Ltd
AU:HMD |
Medical Devices | 0.83% |
Annual Asset Resilience Ratio for InfuSystems Holdings Inc (2006–2017)
The table below shows the annual Asset Resilience Ratio data for InfuSystems Holdings Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2017-12-31 | 0.00% | $0.00 | $68.88 Million | -- |
| 2016-12-31 | 0.00% | $0.00 | $96.34 Million | -- |
| 2015-12-31 | 0.00% | $0.00 | $96.45 Million | -- |
| 2014-12-31 | 0.00% | $0.00 | $80.21 Million | -- |
| 2013-12-31 | 0.00% | $0.00 | $77.37 Million | -- |
| 2012-12-31 | 0.00% | $0.00 | $77.52 Million | -- |
| 2011-12-31 | 0.00% | $0.00 | $76.26 Million | -- |
| 2006-12-31 | 97.86% | $98.15 Million | $100.30 Million | -- |
About InfuSystems Holdings Inc
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates through two segments: Patient Services and Device Solutions. The company supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment … Read more